Biricodar

Biricodar
Clinical data
ATC code	none;
Identifiers
	IUPAC name 1,7-di(pyridin-3-yl)heptan-4-yl (2S)-1-[oxo(3,4,5-trimethoxyphenyl)acetyl]piperidine-2-carboxylate;
CAS Number	174254-13-8 ;
PubChem CID	3037617;
ChemSpider	2301309 ;
UNII	9WQP0L619L;
ChEMBL	CHEMBL350775 ;
Chemical and physical data
Formula	C34H41N3O7
Molar mass	603.705 g/mol
3D model (JSmol)	Interactive image;
	SMILES O=C(C(=O)c1cc(OC)c(OC)c(OC)c1)N4[C@H](C(=O)OC(CCCc2cccnc2)CCCc3cccnc3)CCCC4;
	InChI InChI=1S/C34H41N3O7/c1-41-29-20-26(21-30(42-2)32(29)43-3)31(38)33(39)37-19-5-4-16-28(37)34(40)44-27(14-6-10-24-12-8-17-35-22-24)15-7-11-25-13-9-18-36-23-25/h8-9,12-13,17-18,20-23,27-28H,4-7,10-11,14-16,19H2,1-3H3/t28-/m0/s1 ; Key:CGVWPQOFHSAKRR-NDEPHWFRSA-N ;
(verify)

Biricodar (INN, codename VX-710) was a pharmaceutical drug under development by Vertex Pharmaceuticals to help treat ovarian cancer patients, that never reached the market.

External links

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

Clinical data

ATC code	none
Identifiers
IUPAC name 1,7-di(pyridin-3-yl)heptan-4-yl (2S)-1-[oxo(3,4,5-trimethoxyphenyl)acetyl]piperidine-2-carboxylate
CAS Number	174254-13-8^Y
PubChem CID	3037617
ChemSpider	2301309^Y
UNII	9WQP0L619L
ChEMBL	CHEMBL350775^Y
Chemical and physical data
Formula	C₃₄H₄₁N₃O₇
Molar mass	603.705 g/mol
3D model (JSmol)	Interactive image
SMILES O=C(C(=O)c1cc(OC)c(OC)c(OC)c1)N4[C@H](C(=O)OC(CCCc2cccnc2)CCCc3cccnc3)CCCC4
InChI InChI=1S/C34H41N3O7/c1-41-29-20-26(21-30(42-2)32(29)43-3)31(38)33(39)37-19-5-4-16-28(37)34(40)44-27(14-6-10-24-12-8-17-35-22-24)15-7-11-25-13-9-18-36-23-25/h8-9,12-13,17-18,20-23,27-28H,4-7,10-11,14-16,19H2,1-3H3/t28-/m0/s1^Y Key:CGVWPQOFHSAKRR-NDEPHWFRSA-N^Y
(verify)